臨床試験サプライ＆ロジスティクス市場：サービス、調達モデル、タイプ、配送形態、エンドユーザー、治療領域、臨床試験のフェーズ別-2025-2030年世界予測

臨床試験サプライ＆ロジスティクス市場は、2023年に243億3,000万米ドルと評価され、2024年にはCAGR 7.75%で262億米ドルに成長し、2030年には410億4,000万米ドルに達すると予測されています。

ペースの速い今日の環境において、治験薬供給・ロジスティクス部門は医薬品開発プロセスの重要な歯車となっています。かつては伝統的な手法であった臨床試験も、複雑な研究プロトコール、高まる規制状況、臨床試験実施施設の世界ネットワークなど、ますます厳しくなる情勢に対応するため、急速に進化しています。本レポートは、業界で台頭しつつある最先端の手法の包括的な概要を提供し、市場力学の詳細な調査のための舞台を整えるものです。最先端の技術、革新的な調達戦略、そして臨床試験の各段階のニュアンスに対応する適応性の高いロジスティクス・ソリューションの融合によって、このような物語が構築されています。機密性の高い治験薬の完全性とタイムリーな配送の両方を維持することの重要性を認識し、業界のリーダーたちはサプライチェーンの再構築を余儀なくされています。業界がより統合的で全体的なアプローチに向かうにつれ、製造や包装からラベリングや保管に至るまで、あらゆる面が精査の対象となっています。このディスカッションでは、新規治療薬を必要とする人々に効率的かつ安全に届けるため、様々な利害関係者が取った業務の合理化に関する先進的な取り組みについて紹介します。

臨床試験の情勢を形成する変革的変化

近年、臨床試験業界では、治験薬の管理方法を再定義するような、いくつかの変革的な変化が起きています。デジタルコネクティビティの進化と堅牢なデータ分析が相まって、より予測的で迅速なロジスティクス戦略への道が開かれました。利害関係者は、サプライチェーンに比類のない可視性を提供するクラウドベースのプラットフォームやリアルタイムの追跡システムをますます活用するようになっています。これにより、混乱リスクを最小限に抑えるだけでなく、あらゆる局面での意思決定プロセスを強化することができます。持続可能で機敏なオペレーションを目指す動きは、温度管理されたロジスティクスの革新にさらに拍車をかけ、機密性の高い生物学的物質が輸送中もその完全性を維持できるようにしています。さらに、セクターを超えた連携により、先進的な製造技術や自動パッケージングプロセスの統合が進んでいます。このような変化は、臨床試験の現場全体に波及する業務効率化をもたらしました。技術が進化するにつれて、従来の役割の境界が曖昧になり、コスト管理と品質保証のバランスを最適化する専門知識の融合が到来しています。このような変革的シフトは、現代の臨床試験のダイナミックなニーズに対応し、かつ弾力性のある供給エコシステムの基礎を築きつつあります。

市場力学を牽引する主なセグメンテーション洞察

臨床試験の供給とロジスティクスの複雑な力学を読み解くには、市場セグメンテーションを精緻に理解することが最も重要です。分析は、提供されるサービスから始まり、様々な次元で分類されます。市場は、コンパレータの調達、包括的なロジスティクスと流通、精密な製造、詳細な包装、正確なラベリングと盲検化、さらに重要な保管と保存などの側面にわたって解剖されます。ロジスティクスの中では、温度に敏感な生物製剤を維持するために不可欠なコールドチェーン流通方法と、より広範な医療製品に対応する非コールドチェーン流通オプションに進化がさらに細分化されています。さらに、調達モデルは集中型と分散型のアプローチに焦点を当てて精査され、それぞれが効率とコストの最適化という点で独自の利点を提示しています。また、生物学的製剤、先端医療機器、低分子治療薬など、製品のタイプを検討する際にも、市場の差別化が重要になります。さらに、タイミングと資源配分に重要な意味を持つオフサイト供給管理とオンサイト供給管理を対比することで、供給形態を精査しています。エンドユーザー分析では、開発業務受託機関や医療機器企業から製薬企業やバイオテクノロジー企業に至るまで、さまざまな利害関係者の多様で専門的なニーズを明らかにしています。最後に、血液疾患から呼吸器系の課題までの治療領域は、BA/BE試験からフェーズ4までの臨床試験の複数のフェーズの評価によって補完され、市場のニーズと機会を正確に評価するためのニュアンスに富んだレンズを提供しています。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 臨床試験の世界化と規制の調和
    • 慢性疾患の発生率が上昇する中、経済全体で医薬品研究開発活動を強化するための政府資金の増加
  • 抑制要因
    • テクノロジーの統合とデータ管理に関連する問題
  • 機会
    • 製薬メーカーとCDMOの提携活動の増加
    • サプライチェーン最適化における予測分析のための人工知能と機械学習の統合
  • 課題
    • 臨床試験の供給と物流における業務に関連する懸念
• 市場セグメンテーション分析
  • サービス：需要の増加に伴い、コールドチェーン配送サービスの継続的な進歩
  • タイプ：医薬品分野における低分子化合物の利用の急増
  • 提供方法：複数拠点での試験実施のためのオフサイトソリューションの採用が増加
  • 調達モデル：供給分配のスピードと効率を高めるための分散型調達モデルの需要の高まり
  • フェーズ：フェーズ3臨床試験における供給および物流サービスの範囲の拡大
  • 治療領域：腫瘍学における民間および公共部門の投資と調査活動の急増
  • エンドユーザー：製薬会社およびバイオテクノロジー企業による臨床試験サプライ＆ロジスティクスの使用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社会
  • 技術的
  • 法律上
  • 環境

第6章 臨床試験サプライ＆ロジスティクス市場：サービス別

• 比較調達
• 物流・流通
  • コールドチェーン配送
  • 非コールドチェーン配送
• 製造業
• 包装、ラベル、ブラインド
• 保管と保持

第7章 臨床試験サプライ＆ロジスティクス市場調達モデル別

• 集中調達
• 分散型ソーシング

第8章 臨床試験サプライ＆ロジスティクス市場：タイプ別

• 生物学的製剤
• 医療機器
• 小分子

第9章 臨床試験サプライ＆ロジスティクス市場配送方法別

• オフサイト供給管理
• オンサイト供給管理

第10章 臨床試験サプライ＆ロジスティクス市場：エンドユーザー別

• 契約調査機関
• 医療機器企業
• 製薬・バイオテクノロジー企業

第11章 臨床試験サプライ＆ロジスティクス市場治療領域別

• 血液疾患
• 心血管疾患
• 中枢神経系および精神障害
• 皮膚疾患
• 消化器疾患
• 耳鼻咽喉科疾患
• 免疫学
• 感染症
• 代謝障害
• 腎臓学
• 腫瘍学
• 希少疾患
• 呼吸器疾患

第12章 臨床試験サプライ＆ロジスティクス市場臨床試験の段階別

• BA/BE研究
• フェーズ1
• フェーズ2
• フェーズ3
• フェーズ4

第13章 南北アメリカの臨床試験サプライ＆ロジスティクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第14章 アジア太平洋地域の臨床試験サプライ＆ロジスティクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第15章 欧州・中東・アフリカの臨床試験サプライ＆ロジスティクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第16章 競合情勢

• 市場シェア分析, 2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acnos Pharma GmbH
• ADAllen Pharma Ltd
• Almac Group Limited
• Ancillare, LP
• Avantor, Inc.
• Beroe Holdings Inc.
• Biocair International Limited
• Calyx
• Catalent, Inc.
• Clinical Services International LTD
• Clinigen Group PLC
• COREX LOGISTICS LIMITED
• DHL Group
• Eurofins Scientific SE
• Experic, LLC
• FedEx Corporation
• ICON PLC
• Inceptua S.A.
• Infosys Limited
• IPS Pharma
• KLIFO A/S
• Lonza Group AG
• Marken Limited by United Parcel Service, Inc.
• Microsoft Corporation
• Myonex, Inc.
• N-SIDE SA
• NUVISAN GmbH
• OCT Clinical GmbH
• Octalsoft
• Parexel International Corporation
• PCI Pharma Services
• PHOENIX Pharmahandel GmbH & Co KG
• Piramal Pharma Limited
• Recipharm AB
• SAP SE
• Sharp Services, LLC
• Signant Health
• SIRO Clinpharm Private Limited
• Thermo Fisher Scientific Inc.
• Tower Cold Chain Solutions
• Uniphar PLC
• Walden Group
• Zuellig Pharma Pte Ltd by Interpharma Investments Limited

LIST OF FIGURES

• FIGURE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET MULTI-CURRENCY
• FIGURE 2. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET MULTI-LANGUAGE
• FIGURE 3. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET RESEARCH PROCESS
• FIGURE 4. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2023 VS 2030
• FIGURE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
• FIGURE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2023 VS 2030 (%)
• FIGURE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 25. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 26. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 27. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 28. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 29. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 30. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 31. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CLINICAL TRIAL SUPPLY & LOGISTICS MARKET DYNAMICS
• TABLE 7. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COMPARATOR SOURCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NON-COLD CHAIN DISTRIBUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PACKAGING, LABELING, & BLINDING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STORAGE & RETENTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CENTRALIZED SOURCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DECENTRALIZED SOURCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BIOLOGIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY OFFSITE SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONSITE SUPPLY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CONTRACT RESEARCH ORGANISATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MEDICAL DEVICES COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY CNS & MENTAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DERMATOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY DIGESTIVE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ENT DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 44. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 45. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY BA/ BE STUDIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 46. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
• TABLE 47. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
• TABLE 48. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
• TABLE 49. GLOBAL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASE 4, BY REGION, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 51. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 52. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 53. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 55. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 57. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 58. AMERICAS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 60. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 61. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 62. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 64. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 66. ARGENTINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 67. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 68. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 69. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 70. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 72. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 74. BRAZIL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 75. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 76. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 77. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 78. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 80. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 82. CANADA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 83. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 84. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 85. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 86. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 88. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 90. MEXICO CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 91. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 92. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 93. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 94. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 96. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 98. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 99. UNITED STATES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 100. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 101. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 102. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 103. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 104. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 105. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 107. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 108. ASIA-PACIFIC CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 110. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 111. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 112. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 113. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 114. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 116. AUSTRALIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 117. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 118. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 119. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 120. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 122. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 124. CHINA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 125. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 126. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 127. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 128. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 130. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 132. INDIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 133. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 135. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 136. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 138. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 140. INDONESIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 141. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 142. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 143. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 144. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 146. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 148. JAPAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 149. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 150. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 151. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 152. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 153. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 154. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 156. MALAYSIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 157. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 158. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 159. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 160. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 161. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 162. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 164. PHILIPPINES CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 165. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 166. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 167. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 168. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 169. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 170. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 172. SINGAPORE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 174. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 175. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 176. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 178. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 180. SOUTH KOREA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 181. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 182. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 183. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 184. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 185. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 186. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 188. TAIWAN CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 189. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 190. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 191. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 192. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 193. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 194. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 195. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 196. THAILAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 197. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 198. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 199. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 200. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 201. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 202. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 203. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 204. VIETNAM CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 205. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 206. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 207. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 208. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 209. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 210. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 211. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 212. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 213. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 214. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 215. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 216. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 217. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 218. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 219. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 220. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 221. DENMARK CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 222. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 223. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 224. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 225. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 226. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 227. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 228. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 229. EGYPT CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 230. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 231. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 232. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 233. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 234. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 235. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 237. FINLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 238. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 239. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 240. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 241. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 242. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 243. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 244. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 245. FRANCE CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 246. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 247. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 248. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 249. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 250. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 251. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 252. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 253. GERMANY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 254. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 255. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 256. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 257. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 258. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 259. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 260. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 261. ISRAEL CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 262. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 263. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 264. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 265. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 266. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 267. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 268. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 269. ITALY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 270. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 271. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 272. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 273. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 274. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 275. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 276. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 277. NETHERLANDS CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 278. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 279. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 280. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 281. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 282. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 283. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 284. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 285. NIGERIA CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 286. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 287. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD MILLION)
• TABLE 288. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SOURCING MODEL, 2018-2030 (USD MILLION)
• TABLE 289. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 290. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
• TABLE 291. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 292. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
• TABLE 293. NORWAY CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY PHASES OF CLINICAL TRIALS, 2018-2030 (USD MILLION)
• TABLE 294. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 295. POLAND CLINICAL TRIAL SUPPLY & LOGISTICS MARKET SIZE, BY LOGISTICS & DISTRIBUTION, 2018-2030 (USD

The Clinical Trial Supply & Logistics Market was valued at USD 24.33 billion in 2023 and is projected to grow to USD 26.20 billion in 2024, with a CAGR of 7.75%, reaching USD 41.04 billion by 2030.

In today's fast-paced environment, the clinical trial supply and logistics sector stands as a vital cog in the drug development process. The once traditional methods are rapidly evolving to address an increasingly demanding landscape, characterized by complex research protocols, heightened regulatory requirements, and a global network of clinical sites. This report offers a comprehensive overview of the state-of-the-art methodologies emerging in the industry and sets the stage for an in-depth examination of market dynamics. The narrative is built on the convergence of cutting-edge technologies, innovative sourcing strategies, and adaptive logistics solutions that cater to the nuances of clinical trials at every stage. Recognizing the importance of maintaining both the integrity and timely delivery of sensitive trial materials, industry leaders have been compelled to reimagine their supply chains. As the industry moves towards a more integrated and holistic approach, every facet-from manufacturing and packaging to labeling and storage-has come under scrutiny. The discussion highlights the progressive steps taken by various stakeholders to streamline operations, ensuring that novel therapies reach those in need efficiently and safely.

Transformative Shifts Reshaping the Clinical Trial Landscape

Over recent years, the industry has witnessed several transformative shifts that have redefined how clinical trial supplies are managed. Advancements in digital connectivity, combined with robust data analytics, have paved the way for more predictive and responsive logistic strategies. Stakeholders are increasingly leveraging cloud-based platforms and real-time tracking systems that offer unparalleled visibility into the supply chain. This not only minimizes the risk of disruption but also enhances decision-making processes at every juncture. A move towards sustainable and agile operations has further spurred innovations in temperature-controlled logistics, ensuring that sensitive biological materials maintain their integrity during transit. Moreover, collaborations across sectors have led to the integration of advanced manufacturing techniques and automated packaging processes. Such changes have resulted in operational efficiencies that ripple throughout the clinical trial landscape. As techniques evolve, the boundaries between traditional roles blur, ushering in a convergence of expertise that optimizes the balance between cost management and quality assurance. These transformative shifts are laying the foundation for a supply ecosystem that is both resilient and responsive to the dynamic needs of modern clinical trials.

Key Segmentation Insights Driving Market Dynamics

A refined understanding of the market segmentation is paramount for deciphering the intricate dynamics of clinical trial supply and logistics. The analysis is categorized under various dimensions beginning with the services provided. The market is dissected across facets including comparator sourcing, comprehensive logistics and distribution, precise manufacturing, detailed packaging, accurate labeling and blinding, as well as critical storage and retention. Within logistics, the evolution is further delineated into cold chain distribution methods that are essential for maintaining temperature-sensitive biologics and non-cold chain distribution options catering to a broader spectrum of medical products. Additionally, sourcing models are scrutinized with a focus on centralized versus decentralized approaches, each presenting unique benefits in terms of efficiency and cost optimization. Critical market differentiation also emerges when examining the types of products, spanning biologic drugs, advanced medical devices, and small molecule therapies. Furthermore, the mode of delivery is scrutinized by contrasting offsite supply management against onsite supply management, which has significant implications on timing and resource allocation. End-user analysis extends from contract research organizations and medical devices companies to pharmaceutical and biotechnology companies, underscoring the diverse and specialized needs of various stakeholders. Lastly, therapeutic areas from blood disorders to respiratory challenges, complemented by an evaluation of multiple phases of clinical trials from BA/BE studies through Phase 4, provide a nuanced lens through which market needs and opportunities can be accurately assessed.

Based on Services, market is studied across Comparator Sourcing, Logistics & Distribution, Manufacturing, Packaging, Labeling, & Blinding, and Storage & Retention. The Logistics & Distribution is further studied across Cold Chain Distribution and Non-Cold Chain Distribution.

Based on Sourcing Model, market is studied across Centralized Sourcing and Decentralized Sourcing.

Based on Type, market is studied across Biologic Drugs, Medical Devices, and Small Molecules.

Based on Mode of Delivery, market is studied across Offsite Supply Management and Onsite Supply Management.

Based on End-user, market is studied across Contract Research Organisations, Medical Devices Companies, and Pharmaceutical & Biotechnology Companies.

Based on Therapeutic Area, market is studied across Blood Disorders, Cardiovascular Diseases, CNS & Mental Disorders, Dermatological Disorders, Digestive Disorders, ENT Diseases, Immunology, Infectious Diseases, Metabolic Disorders, Nephrology, Oncology, Rare Diseases, and Respiratory Disorders.

Based on Phases of Clinical Trials, market is studied across BA/ BE studies, Phase 1, Phase 2, Phase 3, and Phase 4.

Regional Dynamics and Market Opportunities

The clinical trial supply and logistics market is visibly segmented by distinct regional trends that influence strategic decisions and operational frameworks. In the Americas, mature regulatory landscapes and advanced healthcare infrastructures are propelling market growth, with a particular focus on innovations that improve trial efficiencies and reduce lead times. Meanwhile, the combined dynamics of Europe, the Middle East, and Africa present a compelling mix of regulatory rigor and emerging opportunities. These regions are harnessing the benefits of technological integration and collaborative supply chain practices to tackle unique challenges intrinsic to local healthcare systems. The Asia-Pacific region is rapidly asserting its position on the global stage as an epicenter for clinical research and development. Driven by substantial investments in research infrastructure and a vast patient demographic pool, the region is witnessing remarkable improvements in logistics capabilities and an increasing adoption of technology-driven solutions. In each of these markets, the balance between localized operational strategies and global best practices is key to sustaining momentum and fostering growth. Understanding these geographical nuances not only enhances the ability to anticipate market shifts but also empowers stakeholders to design region-specific strategies that align with broader global trends.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Massachusetts, Minnesota, New York, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Leading Players and Competitive Strategies

The market landscape is further enriched by a competitive array of key companies that have robustly positioned themselves at various stages of the clinical trial supply chain. Companies such as Acnos Pharma GmbH and ADAllen Pharma Ltd have developed specialized capabilities in supply chain management, while industry leaders including Almac Group Limited, Ancillare, LP, and Avantor, Inc. continue to push boundaries with innovative logistical solutions. Other notable players such as Beroe Holdings Inc. and Biocair International Limited are known for their stringent quality controls and reliable distribution networks. The competitive environment is bolstered by significant contributions from Calyx, Catalent, Inc., and Clinical Services International LTD, along with influential operations led by Clinigen Group PLC and COREX LOGISTICS LIMITED. Furthermore, global logistics giants like DHL Group, FedEx Corporation, and Tower Cold Chain Solutions are instrumental in driving supply chain optimization. In this complex ecosystem, organizations including Eurofins Scientific SE, Experic, LLC, ICON PLC, and Inceptua S.A. have also emerged as front-runners. The presence of technology powerhouses such as Infosys Limited and SAP SE, combined with strong performances from specialized entities like IPS Pharma and KLIFO A/S, enriches the competitive tapestry. Collectively, these players contribute to a dynamic market environment that rewards innovation, operational excellence, and a commitment to sustained improvement in clinical supply chain processes.

The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include Acnos Pharma GmbH, ADAllen Pharma Ltd, Almac Group Limited, Ancillare, LP, Avantor, Inc., Beroe Holdings Inc., Biocair International Limited, Calyx, Catalent, Inc., Clinical Services International LTD, Clinigen Group PLC, COREX LOGISTICS LIMITED, DHL Group, Eurofins Scientific SE, Experic, LLC, FedEx Corporation, ICON PLC, Inceptua S.A., Infosys Limited, IPS Pharma, KLIFO A/S, Lonza Group AG, Marken Limited by United Parcel Service, Inc., Microsoft Corporation, Myonex, Inc., N-SIDE SA, NUVISAN GmbH, OCT Clinical GmbH, Octalsoft, Parexel International Corporation, PCI Pharma Services, PHOENIX Pharmahandel GmbH & Co KG, Piramal Pharma Limited, Recipharm AB, SAP SE, Sharp Services, LLC, Signant Health, SIRO Clinpharm Private Limited, Thermo Fisher Scientific Inc., Tower Cold Chain Solutions, Uniphar PLC, Walden Group, and Zuellig Pharma Pte Ltd by Interpharma Investments Limited. Actionable Recommendations for Advancing Market Leadership

Industry leaders are encouraged to embrace a multi-pronged approach to secure a competitive edge and streamline operations in a rapidly evolving market. First, there is an immediate need to invest in digital transformation initiatives, including the integration of real-time tracking systems and advanced analytics platforms to foster greater supply chain visibility and risk mitigation. It is essential to cultivate partnerships that bridge the gaps between manufacturing, packaging, and distribution, ensuring that the entire supply chain remains cohesive and resilient. Emphasizing a shift towards centralized or, where beneficial, decentralized sourcing strategies can help optimize resource allocation and manage regional demands effectively. Furthermore, aligning with specialized service providers that offer bespoke solutions across comparator sourcing and cold chain logistics will fortify the ability to handle sensitive trial materials. Leaders should also consider diversifying their operational frameworks by leveraging offsite and onsite supply management models that accommodate the evolving requirements of varied therapeutic areas and clinical trial phases. Strategic investments in automation, data analytics, and sustainable logistic practices can dramatically reduce turnaround times while enhancing cost efficiency. Embracing these actionable strategies not only reinforces current operational frameworks but also positions organizations to anticipate future market challenges with agility and precision.

Conclusion and Forward Outlook

In summary, the clinical trial supply and logistics market is undergoing a significant transformation driven by technological advancements and innovative operational strategies. The integrated approach to managing segmented market needs-from services and sourcing models to therapeutic areas and trial phases-underscores a deep commitment to enhancing efficiency and ensuring the successful execution of clinical research. As regional markets evolve and competitive pressures intensify, a strategic, data-informed, and agile methodology remains a critical success factor. The momentum generated by these evolving trends paints an optimistic future where operational excellence and technological integration coalesce to drive transformative outcomes across the industry.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Globalization of clinical trials and harmonization of regulations
    • 5.1.1.2. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
  • 5.1.2. Restraints
    • 5.1.2.1. Problems associated with technology integration and data management
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
    • 5.1.3.2. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
  • 5.1.4. Challenges
    • 5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
• 5.2. Market Segmentation Analysis
  • 5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
  • 5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
  • 5.2.3. Mode of Delivery: Growing adoption of offsite solutions for multi-site trials delivery
  • 5.2.4. Sourcing Model: Rising demand for decentralized sourcing models to enhance the speed and efficiency of supply distribution
  • 5.2.5. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
  • 5.2.6. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
  • 5.2.7. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Clinical Trial Supply & Logistics Market, by Services

• 6.1. Introduction
• 6.2. Comparator Sourcing
• 6.3. Logistics & Distribution
  • 6.3.1. Cold Chain Distribution
  • 6.3.2. Non-Cold Chain Distribution
• 6.4. Manufacturing
• 6.5. Packaging, Labeling, & Blinding
• 6.6. Storage & Retention

7. Clinical Trial Supply & Logistics Market, by Sourcing Model

• 7.1. Introduction
• 7.2. Centralized Sourcing
• 7.3. Decentralized Sourcing

8. Clinical Trial Supply & Logistics Market, by Type

• 8.1. Introduction
• 8.2. Biologic Drugs
• 8.3. Medical Devices
• 8.4. Small Molecules

9. Clinical Trial Supply & Logistics Market, by Mode of Delivery

• 9.1. Introduction
• 9.2. Offsite Supply Management
• 9.3. Onsite Supply Management

10. Clinical Trial Supply & Logistics Market, by End-user

• 10.1. Introduction
• 10.2. Contract Research Organisations
• 10.3. Medical Devices Companies
• 10.4. Pharmaceutical & Biotechnology Companies

11. Clinical Trial Supply & Logistics Market, by Therapeutic Area

• 11.1. Introduction
• 11.2. Blood Disorders
• 11.3. Cardiovascular Diseases
• 11.4. CNS & Mental Disorders
• 11.5. Dermatological Disorders
• 11.6. Digestive Disorders
• 11.7. ENT Diseases
• 11.8. Immunology
• 11.9. Infectious Diseases
• 11.10. Metabolic Disorders
• 11.11. Nephrology
• 11.12. Oncology
• 11.13. Rare Diseases
• 11.14. Respiratory Disorders

12. Clinical Trial Supply & Logistics Market, by Phases of Clinical Trials

• 12.1. Introduction
• 12.2. BA/ BE studies
• 12.3. Phase 1
• 12.4. Phase 2
• 12.5. Phase 3
• 12.6. Phase 4

13. Americas Clinical Trial Supply & Logistics Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Clinical Trial Supply & Logistics Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
  • 16.3.1. Catalent strengthens European supply chain with USD 25 million expansion of Schorndorf facility, enhancing FastChain capabilities
  • 16.3.2. Experic strategically expands to Europe with a new Dublin facility enhancing global clinical trial supply and logistics services
  • 16.3.3. FedEx fortifies its global clinical trial logistics with a new life science center in Mumbai, enhancing healthcare supply chain connectivity
  • 16.3.4. PCM Trials acquires Netherlands-based clinical trial service
  • 16.3.5. Piramal Pharma solutions commemorates opening of its ADC manufacturing expansion in Grangemouth, Scotland
  • 16.3.6. Biocair announces the U.S. expansion as part Of global growth strategy
  • 16.3.7. Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs
  • 16.3.8. Piramal Pharma Solutions launches in-vitro biology capabilities at Ahmedabad discovery services site
  • 16.3.9. Signant Health Launches Signant Biotech to accelerate and streamline clinical development for emerging biopharmaceutical organizations
  • 16.3.10. N-SIDE introduces Lighthouse, innovative software to shape the future of worldwide clinical trial supply management
  • 16.3.11. Zuellig Pharma and GSK establish a vaccine distribution hub in Singapore
  • 16.3.12. Ariceum Therapeutics and Eurofins CDMO sign a pharmaceutical multi-project agreement
  • 16.3.13. Vial announces strategic partnership with Royale International Group
  • 16.3.14. Biocair partners with TrakCel to improve visibility in the supply chain
  • 16.3.15. IDEAYA expands clinical trial collaboration and supply agreements with Pfizer
  • 16.3.16. Calyx introduces new clinical trial supply forecasting service
  • 16.3.17. Catalent completes expansion of Singapore clinical supply facility for increased temperature-controlled capabilities
• 16.4. Strategy Analysis & Recommendation
  • 16.4.1. Almac Group Limited
  • 16.4.2. Catalent, Inc.
  • 16.4.3. DHL Group
  • 16.4.4. Walden Group

Companies Mentioned

• 1. Acnos Pharma GmbH
• 2. ADAllen Pharma Ltd
• 3. Almac Group Limited
• 4. Ancillare, LP
• 5. Avantor, Inc.
• 6. Beroe Holdings Inc.
• 7. Biocair International Limited
• 8. Calyx
• 9. Catalent, Inc.
• 10. Clinical Services International LTD
• 11. Clinigen Group PLC
• 12. COREX LOGISTICS LIMITED
• 13. DHL Group
• 14. Eurofins Scientific SE
• 15. Experic, LLC
• 16. FedEx Corporation
• 17. ICON PLC
• 18. Inceptua S.A.
• 19. Infosys Limited
• 20. IPS Pharma
• 21. KLIFO A/S
• 22. Lonza Group AG
• 23. Marken Limited by United Parcel Service, Inc.
• 24. Microsoft Corporation
• 25. Myonex, Inc.
• 26. N-SIDE SA
• 27. NUVISAN GmbH
• 28. OCT Clinical GmbH
• 29. Octalsoft
• 30. Parexel International Corporation
• 31. PCI Pharma Services
• 32. PHOENIX Pharmahandel GmbH & Co KG
• 33. Piramal Pharma Limited
• 34. Recipharm AB
• 35. SAP SE
• 36. Sharp Services, LLC
• 37. Signant Health
• 38. SIRO Clinpharm Private Limited
• 39. Thermo Fisher Scientific Inc.
• 40. Tower Cold Chain Solutions
• 41. Uniphar PLC
• 42. Walden Group
• 43. Zuellig Pharma Pte Ltd by Interpharma Investments Limited